Merck KGaA (MRK) Given a €91.00 Price Target at equinet AG
Merck KGaA (FRA:MRK) has been given a €91.00 ($101.11) price objective by equities researchers at equinet AG in a research report issued on Friday. The brokerage presently has a a “neutral” rating on the stock.
A number of other research analysts have also commented on the stock. Commerzbank AG set a €101.00 ($112.22) price objective on shares of Merck KGaA and gave the company a “buy” rating in a research note on Friday, July 22nd. Citigroup Inc. set a €115.00 ($127.78) price objective on shares of Merck KGaA and gave the company a “buy” rating in a research note on Tuesday, July 26th. JPMorgan Chase & Co. reiterated a “neutral” rating on shares of Merck KGaA in a research note on Thursday, July 21st. Deutsche Bank AG set a €110.00 ($122.22) price objective on shares of Merck KGaA and gave the company a “buy” rating in a research note on Thursday, July 28th. Finally, Berenberg Bank set a €101.00 ($112.22) price objective on shares of Merck KGaA and gave the company a “neutral” rating in a research note on Friday, August 12th. One analyst has rated the stock with a sell rating, twelve have given a hold rating and ten have issued a buy rating to the company. The stock presently has an average rating of “Hold” and a consensus price target of €100.82 ($112.03).
Merck KGaA (FRA:MRK) opened at 97.00 on Friday. The stock has a market cap of €42.17 billion and a price-to-earnings ratio of 30.35. Merck KGaA has a 52 week low of €70.87 and a 52 week high of €100.00. The firm’s 50 day moving average price is €95.74 and its 200-day moving average price is €89.91.
This story is the sole property of American Banking News and it was originally published by American Banking News. If you are reading this story on another website, that means this article was illegally copied and re-published to this website in violation of U.S. and International copyright law. The original version of this article is available at https://www.americanbankingnews.com/2016/10/14/merck-kgaa-mrk-given-a-91-00-price-target-at-equinet-ag.html
Merck KGaA Company Profile
Receive News & Ratings for Merck KGaA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Merck KGaA and related companies with MarketBeat.com's FREE daily email newsletter.